Hangzhou Gongze Pharmaceutical Technology Co., Ltd. is a pharmaceutical technology unit that integrates the research, development, and sales of pharmaceutical intermediates, chemical drug derivatives, related fine chemicals, and other rare chemical products and drugs. It also provides compound design, synthesis, and advanced technical support. The company has successfully developed active pharmaceutical ingredients such as Erlotinib, Sunitinib, Conivaptan Hydrochloride, and Darunavir.

　　   In its early development stages, the company focused its resources and efforts on market-oriented discovery and development of pharmaceutical intermediates and active pharmaceutical ingredients. Adhering to a market-driven approach with robust R&D support, the company continues to grow and strengthen based on its own capabilities.